Exemestane is a generic prescription medication. The Food and Drug Administration (FDA) has approved it for: adjuvant (add-on) treatment of early estrogen receptor-positive (ER+) breast cancer, treatment of advanced breast cancer. Exemestane is used in females* who’ve gone through menopause and have tried the medication tamoxifen (Soltamox) to treat their breast cancer. For more information about exemestane’s uses, talk with your doctor.
Are you looking for or in search of FDA approved “Exemestane tablets in India”? “Medicant Healthcare” a registered pharmacy firm in India deals in both brand name as well as generic name Drugs / medicine approved for Breast Cancer. Need Access of Exemestane tablets, get in touch with our healthcare professional.
Exemestane is indicated for the adjuvant treatment of postmenopausal women with estrogen-receptor positive early breast cancer who have received two to three years of tamoxifen and are switched to it for completion of a total of five consecutive years of adjuvant hormonal therapy. US FDA approval was in October 1999.
Exemestane is also indicated for the treatment of advanced breast cancer in postmenopausal women whose disease has progressed following tamoxifen therapy.
Some fast facts about Aromasin:
- Trade Name of the Medicinal Product :: Aromasin (Exemestane) Tablets
- Active ingredient: exemestane
- Drug class: aromatase inhibitor
- Drug form: oral tablet
- Company: Pharmacia & Upjohn
- Approval Date: 10/21/1999